Summary: 

This study evaluated the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings.

Jeronimo J, Bansil P, Lim J, et al. International Journal of Gynecological Cancer. 2014;24(3), 576–585.